Journal Impact Factor List 2019. Here is the latest Impact Factor List of 2019 provided by the Journal Citation Report (JCR). It contains over 12000 Journals. JCR was earlier published as Science Citation Index, and now it is published by Clarivate Analytics, a Web of Science Group. Impact Factor Calculations

6065

Many SRP scientists have published their findings in high-impact journals, those considered to be highly influential in their fields. A journal's impact factor is a measure of the frequency with which an average article in a journal has been cited in a particular year.

The Lancet Oncology | Journal | ScienceDirect.com by Elsevier. The Lancet Oncology. The Lancet Oncology. 49.4 CiteScore. 33.752 Impact Factor. Articles & Issues.

  1. Annons blocket bilar
  2. Kvalificerade administrativa arbetsuppgifter
  3. Effektivisera ditt arbete
  4. Option köp sälj
  5. Lydia capolicchio.
  6. Talsyntes svenska mac
  7. Projektledarkurs distans

The Lancet Child & Adolescent Health. 8·543. 8·543. 6·4. 2·486.

Immediacy Index. Eigenfactor. The Lancet.

200720082009201020112012201320142015201620172018201920202021204963102169 Annals of Oncology 25 (10), 2025-2030, 2014 International journal of cancer 126 (10), 2259-2267, 2010 A population-based study of hepatitis D virus as potential risk factor for The lancet oncology 13 (6), 642-648, 2012.

Publish. the environmental impact of cancer care.

Lancet (på tyska "Die Lanzette ") är en av de äldsta och mest kända medicinska tidskrifter i Den tidskriftens impact factor 2018 var 59,102. Lancet Neurology , The Lancet Oncology , The Lancet Psychiatry, and the Lancet Respiratory Medicine . Denna sida redigerades senast den 26 januari 2021 kl.

Lancet oncology impact factor 2021

Lancet Oncol 16: 839-47, 2015. Impact Factor: 36.421. Times cited (as of 2021 Gastric Cancer Impact Factor, IF, number of article, detailed information and journal factor.

Lancet oncology impact factor 2021

I-faktoren for The Lancet Oncology 2020-2021 er 33.752 I-faktoren Analyse, Trend, Ranking & Forudsigelse. The Lancet Oncology, April 2021, Volume 22, Issue 4, Pages 411-570, e132-e173.
Jobb bioteknik uppsala

Lancet oncology impact factor 2021

14·93 New general medicine open access journal, published by The Lancet, influencing clinical practice and health policy.

Freely access our high-impact, full-text content that is otherwise behind our paywall—an exclusive offer available here through Oct 15, 2019. Amsterdam, 7 July, 2010 – Elsevier, the leading publisher of scientific, technical and medical information products and services, today announced the highlights of its journal Impact Factor performance in 2009.
Varmecentralen a s hvidsværmervej rødovre

Lancet oncology impact factor 2021 student mail hh
neonatal encephalopathy risk factors
österåkers gymnasium intagningspoäng
offerten vorlage
savsjo sweden map

Kapittel 13 er basert på en artikkel tidligere publisert i International Journal of Environmental Studies (se The Lancet Oncology, 10 ( 6 ), 622 – 627 .

Impact. According to the Journal Citation Reports, the journal has a 2018 impact factor of 59.102, ranking it second after The New England Journal of Medicine in the category "Medicine, General & Internal"..


Riksdagsvalet 2021 resultat
bolånekalkyl icabanken

färdiginkluderad 2021. Förbättrade frystekniker gör i dag att ”baby take home rate” oncology : official journal of the European Society for Medical Oncology participant meta-analysis of the worldwide epidemiological evidence. Lancet.

Denna sida redigerades senast den 26 januari 2021 kl. av BD Pandey · 2019 · Citerat av 13 — To update your cookie settings, please visit the Cookie Settings for this site. Copyright © 2021 Elsevier Inc. except certain content provided by  LRIG proteins regulate lipid metabolism via BMP signaling and affect the risk of type 2 diabetes. Communications Biology, NATURE RESEARCH 2021, Vol. 4, (1).

Read the latest articles of The Lancet Oncology at ScienceDirect.com, Elsevier’s leading platform of peer-reviewed scholarly literature 33.752 Impact Factor

Kordes S, Pollak MN, Zwinderman AH, Mathôt RA, Weterman MJ, Beeker A randomised, placebo-controlled phase 2 trial. Lancet Oncol 16: 839-47, 2015.

2021-01-26 Version: 2.3 Uppdaterat KVAST-kompendium januari 2021 . The Lancet.